04.05.2014 Views

National Action Plan for Bone Health - Osteogenesis Imperfecta ...

National Action Plan for Bone Health - Osteogenesis Imperfecta ...

National Action Plan for Bone Health - Osteogenesis Imperfecta ...

SHOW MORE
SHOW LESS

Create successful ePaper yourself

Turn your PDF publications into a flip-book with our unique Google optimized e-Paper software.

The promotion of prevention and treatment measures <strong>for</strong> individuals with osteoporosis,<br />

Paget’s disease, or low bone mass also suffered a setback with the widespread media<br />

coverage of possible associations between the use of bisphosphonates commonly used<br />

to inhibit bone loss in individuals with or at risk of bone disease, and a condition called<br />

osteonecrosis of the jaw (ONJ). ONJ involves the exposure of the bone of the upper or<br />

lower jaw due to dental extraction or trauma, causing a painful wound that does not<br />

heal. More than 90% of cases of ONJ occur in patients who have been given multiple<br />

doses of intravenous bisphosphonates to prevent or treat bone metastases. An ASBMR<br />

task <strong>for</strong>ce reviewed available in<strong>for</strong>mation and estimated that the risk of ONJ associated<br />

with bisphosphonate treatment <strong>for</strong> osteoporosis is low, between 1 to 10 per 100,000<br />

patient treatment years. 23 The risk of ONJ in cancer patients treated with high doses of<br />

intravenous bisphosphonates is much higher, in the range of 1to 10 per 100 patients.<br />

Although the risk of ONJ with bisphosphonate use in osteoporosis is very low, the<br />

perceived risk is high due to media attention. As a result, the rate of bisphosphonate<br />

prescriptions and use has dropped, and many dentists no longer treat patients who are<br />

taking bisphosphonates. Balanced in<strong>for</strong>mation on this problem is essential so that the<br />

benefits of therapy will not be denied to patients at risk <strong>for</strong> fractures.<br />

Recent research regarding rates of vitamin D insufficiency indicates a challenge and an<br />

opportunity. Evidence shows that in the United States and around the world, vitamin D<br />

insufficiency may be one of the most commonly unrecognized medical conditions – one<br />

that exposes individuals to a greater risk of bone disease and fracture due to the critical<br />

connection between vitamin D and the body’s ability to absorb calcium and phosphorous.<br />

24 These findings present an opportunity to revisit the recommendations regarding<br />

vitamin D intake or supplementation and explore strategies <strong>for</strong> increasing daily intake.<br />

“Many people don’t<br />

realize that bone is a<br />

living organ, and not<br />

just a stick. To help<br />

people understand<br />

the importance of<br />

bone health, we need<br />

to put a human face<br />

on bone disease.”<br />

—Media Expert<br />

The general public<br />

does not understand<br />

that bone health<br />

spans every age<br />

and ethnic or racial<br />

group, and that men<br />

and women are both<br />

at risk <strong>for</strong> developing<br />

bone disease.<br />

<strong>National</strong> <strong>Action</strong> <strong>Plan</strong> <strong>for</strong> <strong>Bone</strong> <strong>Health</strong>:<br />

Recommendations from the Summit <strong>for</strong> a <strong>National</strong> <strong>Action</strong> <strong>Plan</strong> <strong>for</strong> <strong>Bone</strong> <strong>Health</strong><br />

7

Hooray! Your file is uploaded and ready to be published.

Saved successfully!

Ooh no, something went wrong!